Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy

case-report OA: closed CC0
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-08

This case describes a 59-year-old woman with a rectal tumor diagnosed as combined high-grade serous and large cell neuroendocrine carcinoma, determined to originate from endometriosis 11 years post-hysterectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This paper reports a 59-year-old woman who developed a circumferential, advanced rectal tumor 11 years after hysterectomy, presenting with bloody stools; colonoscopic forceps biopsy initially showed an adenocarcinoma component. Using imaging and surgical pathology after rectal resection with D3 lymph node dissection, the authors found a combined malignancy of high-grade serous carcinoma and large cell neuroendocrine carcinoma, with tumor contiguous to the endometrium in the sub-serosa, and endometriosis determined as the origin of both carcinomas. The main limitation is that this is a single case report, so the findings cannot establish broader incidence or causality. This paper is centrally about endometriosis — it describes malignant transformation of rectal endometriosis into mixed high-grade serous and large cell neuroendocrine carcinoma.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The malignant gastrointestinal endometriosis transformation is represented by endometriosis-associated intestinal tumors. Endometrioid adenocarcinoma and clear cell adenocarcinoma are most common among the endometrial cancers of all organs. Only four cases of mixed serous carcinoma and large cell neuroendocrine carcinoma have been reported, and all these cases originated from the uterus. A 59-year-old woman with a month's history of bloody stools was admitted. She was stable until the hematochezia occurred but is 11 years post-hysterectomy. A circumferential type-3 advanced upper rectum tumor was seen on colonoscopy. Adenocarcinoma was revealed from the forceps biopsies of the type-3 tumor component. Computed tomography showed narrowed lumen with a thickened rectum wall, a continuing mass, and a component on the anorectal side. Swollen lymph nodes were observed around the rectum, but no distant metastatic lymph nodes or organs were found. To treat the lesion, rectal surgical resection with D3 lymph node dissection was performed. Histological examination revealed combined high-grade serous and large cell neuroendocrine carcinomas. Tumor was contiguous to the endometrium in the sub-serosa. Endometriosis was determined to be the origin of both carcinomas. Therefore, endometriosis-associated intestinal tumors should be included in the differential diagnosis when rectal tumors with cystic structures are found post-hysterectomy.
Full text 8,227 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

The malignant gastrointestinal endometriosis transformation is represented by endometriosis-associated intestinal tumors. Endometrioid adenocarcinoma and clear cell adenocarcinoma are most common among the endometrial cancers of all organs. Only four cases of mixed serous carcinoma and large cell neuroendocrine carcinoma have been reported, and all these cases originated from the uterus. A 59-year-old woman with a month’s history of bloody stools was admitted. She was stable until the hematochezia occurred but is 11 years post-hysterectomy. A circumferential type-3 advanced upper rectum tumor was seen on colonoscopy. Adenocarcinoma was revealed from the forceps biopsies of the type-3 tumor component. Computed tomography showed narrowed lumen with a thickened rectum wall, a continuing mass, and a component on the anorectal side. Swollen lymph nodes were observed around the rectum, but no distant metastatic lymph nodes or organs were found. To treat the lesion, rectal surgical resection with D3 lymph node dissection was performed. Histological examination revealed combined high-grade serous and large cell neuroendocrine carcinomas. Tumor was contiguous to the endometrium in the sub-serosa. Endometriosis was determined to be the origin of both carcinomas. Therefore, endometriosis-associated intestinal tumors should be included in the differential diagnosis when rectal tumors with cystic structures are found post-hysterectomy. Similar content being viewed by others

References

Yantiss RK, Clement PB, Young RH. Endometriosis of the intestinal tract: a study of 44 cases of a disease that may cause diverse challenges in clinical and pathologic evaluation. Am J Surg Pathol. 2001;25:445–54. Macafee CH, Greer HL. Intestinal endometriosis. A report of 29 cases and a survey of the literature. J Obstet Gynaecol Br Emp. 1960;67:539–55. Orbuch IK, Reich H, Orbuch M, et al. Laparoscopic treatment of recurrent small bowel obstruction secondary to ileal endometriosis. J Minim Invasive Gynecol. 2007;14:113–5. Paksoy M, Karabiçak I, Ayan F, et al. Intestinal obstruction due to rectal endometriosis. Mt Sinai J Med. 2005;72:405–8. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75:1023–8. Mulvany NJ, Allen DG. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol. 2008;27:49–57. Albores-Saavedra J, Martinez-Benitez B, Luevano E. Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol. 2008;27:333–9. Posligua L, Malpica A, Liu J, et al. Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread. Arch Pathol Lab Med. 2008;132:1821–4. Terada T. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract. 2010;206:420–5. Deodhar KK, Kerkar RA, Suryawanshi P, et al. Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J Cancer Res Ther. 2011;7:211–3. Shahabi S, Pellicciotta I, Hou J, et al. Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors. 2011;3: e41. Makihara N, Maeda T, Nishimura M, et al. Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor. Rare Tumors. 2012;4: e37. Rivera G, Niu S, Chen H, et al. Collision tumor of endometrial large cell neuroendocrine carcinoma and low-grade endometrial stromal sarcoma: a case report and review of the literature. Int J Surg Pathol. 2020;28:569–73. Nguyen ML, Han L, Minors AM, et al. Rare large cell neuroendocrine tumor of the endometrium: a case report and review of the literature. Int J Surg Case Rep. 2013;4:651–5. Erhan Y, Dikmen Y, Yucebilgin MS, et al. Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature. Eur J Gynaecol Oncol. 2004;25:109–12. Pocrnich CE, Ramalingam P, Euscher ED, et al. Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2016;40:577–86. Tu YA, Chen YL, Lin MC, et al. Large cell neuroendocrine carcinoma of the endometrium: a case report and literature review. Taiwan J Obstet Gynecol. 2018;57:144–9. Jenny C, Kimball K, Kilgore L, et al. Large cell neuroendocrine carcinoma of the endometrium: a report and review of the literature. Gynecol Oncol Rep. 2019;28:96–100. Hu R, Jiang J, Song G, et al. Mixed large and small cell neuroendocrine carcinoma of the endometrium with serous carcinoma: a case report and literature review. Medicine. 2019;98: e16433. Hardy LE, Chaudry Z, Wan K, et al. Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium. BMJ Case Rep. 2020;13: e234977. Slavin RE, Krum R, Van Dinh T. Endometriosis-associated intestinal tumors: a clinical and pathological study of 6 cases with a review of the literature. Hum Pathol. 2000;31:456–63. Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017. https://doi.org/10.1007/s11912-017-0617-2. Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 1925;10:1–72. Ariura M, Kasajima R, Miyagi Y, et al. Combined large cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium: a shared gene mutation signature between the two histological components. Int Cancer Conf J. 2017;6:11–5. Abu MA, Sinha P, Totoe L, et al. Endometrial cancer thirteen years after total abdominal hysterectomy and bilateral salpingo-oophorectomy and hormone replacement therapy: a case report. Eur J Gynaecol Oncol. 1997;18:482–3.

Acknowledgements

We would like to express our gratitude to Dr. Yuko Omori of the Tohoku University Department of Investigative Pathology for her pathological evaluation, Dr. Kazunori Otsuka of the Miyagi Cancer Center Department of Medical Oncology for chemotherapy, and all medical staff for their assistance at the Soma General Hospital. Author information Authors and Affiliations Contributions Conceptualization, TY and TH. Methodology, TY, TH, and YW. Formal Analysis, TY Investigation, TY, YW, HS, YT, NA, CH, and HK. Resources, TY, TH, and YW Writing–Original Draft Preparation, TY and TH Writing–Review and Editing, YW and MK. Supervision, HO. All authors have read and approved the final manuscript. Corresponding author Ethics declarations Conflict of interest Takumi Yanagita, Takuto Hikichi, Yuichi Waragai, Hiroshi Shimizu, Yuta Takahashi, Naoto Abe, Choichiro Hashimoto, Hiromi Kumakawa, Masao Kobayakawa, Hiromasa Ohira declare that they have no conflict of interest. Human and animal rights All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent Informed consent was obtained from this patient for being included in the paper. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Yanagita, T., Hikichi, T., Waragai, Y. et al. Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy. Clin J Gastroenterol 16, 366–371 (2023). https://doi.org/10.1007/s12328-023-01769-y Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s12328-023-01769-y

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-17T06:16:55.786923+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-09-17T06:16:15.413818+00:00
License: CC0 · commercial use OK